John has a long and successful track record in developing the strategy and creating the environment to achieve an optimal outcome for his clients. Prior to founding ArchPoint, he was a Managing Director and Co-Head of the Technology banking group at Montgomery & Co., where he led the firm’s efforts in advising growth companies in software and related sectors. Prior to joining Montgomery & Co. in January 2003, John was the senior managing director in Microsoft’s Corporate Development and Strategy group. While there, he developed and led a senior team responsible for a number of key investments and acquisitions and effected more than 30 transactions. Among those transactions, John led the acquisition of Great Plains, Inc., kicking off the company’s move into the enterprise application sector.
Immediately following his tenure at Microsoft, John served as president of the California-based venture capital group ThinkTank LLC, an affiliate of SoftBank. While at ThinkTank, he managed and refined the company’s technology investment portfolio, as well as oversaw the privatization of Buy.com. He has also held senior corporate development and strategy positions with American Express Corporation, First Data Corporation, and HBO & Company (now part of McKesson).
To date, John has managed over 100 strategic investment and acquisition processes. He also has an operating background having himself founded and successfully sold two venture capital-financed technology and services companies. He has been an active board member for both public and private companies in the technology sector.
John holds a Bachelor of Arts in Business/Finance from the University of Minnesota, and has completed post-graduate studies in computer science, management, and marketing, including an executive management program at MIT in advanced technologies in business.
Robin Strongin, President & CEO of Amplify Public Affairs, and Creator and Founder of the award winning Disruptive Women in Health Care blog, advises Federal and state governments, regulatory agencies, Congress, think tanks, nonprofit organizations, corporations, coalitions and trade associations. Before becoming President & CEO of Amplify, a woman-owned business, Robin served as acting Executive Director and Director of Research for the Health Care Technology Institute and worked with GW University’s National Health Policy Forum and the Prospective Payment Assessment Commission (now the Medicare Payment Advisory Commission). Robin was selected as a Presidential Management Intern and worked in the Office of Legislation and Policy of the Health Care Financing Administration (now the Centers for Medicare and Medicaid), in addition to serving in the Office of Congressman James J. Florio (D-NJ). Robin is a member of the Women Business Leaders of the US Health Care Industry Foundation and serves on the following Boards: Kaiser Permanente’s Institute for Health Policy, The Institute for Music and Neurologic Function), The Older Women’s League (OWL), Physician-Parent Caregivers, Consumer Action’s Corporate Advisory Board, and The Hill Newspaper Publisher’s Advisory Board. Robin was named as one of the Women Rocking Health by Rock Health.
Mr. Burton became involved as an investor and as the business leader of Health Catalyst (formerly Healthcare Quality Catalyst), the leader in healthcare data warehousing and analytics, when it was a 3-person startup. During his tenure Health Catalyst has realized triple-digit annualized revenue growth, expanded its platform reach to 79 hospitals impacting over 20 Million patients, grown its employee base to over 60 and expanded its product line to over 40 software solutions. Mr. Burton has held positions such as CEO, President, Board Member and Chief Marketing Officer with a number of other companies, helping to enable these organizations to realize substantial growth and success. He is also the co-founder of HB Ventures, the original investor in Health Catalyst. Prior to Health Catalyst and HB Ventures, Mr. Burton led the Corporate Strategy Group at Micron Technology. He also spent eight years with Hewlett-Packard in Strategy and Management roles, including building and managing a technology infrastructure business. Before joining HP he was an Associate Consultant with the Boston Consulting Group, where he advised healthcare systems and technology companies. Mr. Burton holds an MBA with High Distinction from Harvard University, where he was elected a George F. Baker Scholar, and a BS in economics, magna cum laude, from BYU.
Missy joins Morgenthaler Ventures’ Menlo Park office with more than twenty years of product development and marketing, business development, and policy experience in healthcare and health information technology. Her experience ranges from coordinating high-level policy briefings at senior levels of federal government to launching technology products at Google.
Missy worked at Google for 5 years in health and consumer marketing. She was one of the founding members of Google Health, an online medical records and wellness platform and spearheaded the Google Health Advisory Council. In her later years at Google, she managed and led the search launches marketing team. Prior to her role at Google, Missy worked for the Bush Administration in the Secretary’s Office at the U.S. Department of Health and Human Services (HHS). She was Senior Advisor to Dr. David Brailer, M.D., Ph.D., the first National Coordinator for Health Information Technology (ONC). Before coming to HHS, she worked as Product Marketing Director for CareScience, a healthcare information technology company that developed the first Health Information Exchange (HIE). Prior to her role at CareScience, Missy led the Communications and Research at the Kaiser Family Foundation, a non-partisan, national, healthcare policy think tank. She also worked at Aetna where she spearheaded provider networking and communications during two corporate mergers to help the company enter the managed care space.
She is also a mentor at 500 Startups, a tech incubator and accelerator in the Silicon Valley and a mentor at Health Box, a new healthcare accelerator out of Chicago, IL. She also advises several health 2.0 startup companies in the Silicon Valley. She has published a series of articles and blogs and is a member of HIMSS, served on the CCHIT Task Force on PHRs, the Lance Armstrong International Advisory Council, and the Planned Parenthood International Marketing Advisory Council.
Promod has more than 20 years of experience in the venture capital industry and currently serves as senior managing partner at Norwest Venture Partners (NVP). Promod joined NVP in 1990, and has invested in more than 60 companies since he began his venture career, producing nearly $30B in exit values to date. More than 20 of his portfolio companies have gone public and nearly 35 have been acquired (or have gone public and been acquired). Promod was ranked as a top investor on the annual Forbes Midas List for nine years, and in 2004, Forbes named him as the #1 venture capitalist based on performance over the previous decade. In 2006, Promod was presented with a Global Leadership award from NASSCOM, and he was honored with the 2011 SV Forum Visionary Award based on his outstanding achievements and contributions to the technology industry.
Promod focuses on investments across a wide variety of sectors including systems and IT infrastructure, healthcare IT, software and services. He was an early investor and a board member of Cerent (acquired by Cisco), Cast Iron Systems (acquired by IBM), Siara Systems (acquired by Redback Networks), OnDisplay (acquired by Vignette), Winphoria Networks (acquired by Motorola) and Extreme Networks (Nasdaq: EXTR).
His current investments include Apigee, Appnomic Systems, Brite Semiconductor, CareCloud, Cyan, FireEye, Health Catalyst, InsightsOne, PCH International, Persistent Systems (BSE & NSE: PERSISTENT), Skybox Imaging, Sulekha, Veveo, Virtela and Yatra. Other notable investments and previous board seats include Tivoli Systems (acquired by IBM), Forte Software (acquired by Sun Microsystems), Kiva Software (acquired by Netscape), Information Advantage (acquired by Sterling Software), Arbortext (acquired by PTC), Open-Silicon (acquired by Unicorn Investment Bank), Resonext Communications (acquired by RF Micro Devices), Showcase (acquired by SPSS), Yipes (acquired by Reliance/Flag Telecom), Amberpoint (acquired by Oracle) and ZettaCom (acquired by IDT).
Prior to Norwest Venture Partners, Promod spent 18 years in various operational roles ranging from product development, marketing, Chief Operating Officer and Chief Executive Officer at various public and private companies including Siemens International, Thorn EMI, Emergent Technologies and Dimensional Medicine, Inc.
He received a bachelor of science degree in electrical engineering from the University of Delhi, India. He holds a Ph.D. in electrical engineering from Northwestern University and an MBA from Northwestern’s Kellogg Graduate School of Management, where he serves on the advisory board.
Mr. Brannan has 20 years combined experience as an entrepreneur, public company executive, and venture capitalist. Most recently, Mr. Brannan founded Web.com (formerly Website Pros), one of the largest Cloud Computing/SaaS Services company for the SMB sector. He raised $65M from leading VC firms, growing the company to 700+ employees and achieving a successful IPO. Previously, he founded Verio, the largest global cloud hosting company, where he raised over $1B in capital, growing the company to 2,500 employees and achieving a successful IPO ($1.2B market cap), shortly after Verio sold to NTT for $6.1B in cash (the largest U.S. technology acquisition by a foreign company). While at Verio, Mr. Brannan wrote the plan and helped launch VIANet (an international version of Verio), which also achieved a successful IPO. Prior to his start-up and executive experience, Mr. Brannan worked at two leading Venture Capital Firms, Norwest Venture Partners and Burr, Egan, Deleage & Company, where he helped form companies and played an active role in evaluating and guiding investments in over a dozen private companies that achieved successful IPO’s.
Aimee currently serves as an investor for HealthTech Capital providing seed funding and mentor capital to promising health technology start-ups, and is an angel advisor to the Astia Angel Network funding high-growth start-ups led by women in the areas of entertainment, retail and consumer products. Prior to this, Aimee served as Global Vice President for frogdesign leading the Business Strategy Group initially and then launching their Health & Wellness Practice. Her areas of focus are around mobile and connected technologies, consumer engagement and behavior change, as well as sustainable (profitable) innovation. She specializes in strategy for bringing innovation to market and operates at the nexus of design, technology and business. She is a founding member of the Wharton Design Roundtable incorporating design thinking and human-centered approaches into the traditional MBA curriculum.
Aimee began her career at Accenture as a Senior Director in both Consumer Products and Healthcare. After receiving an MBA at Stanford, Aimee led the venture-funded (eMarkets) segment at Scient serving as one of the leadership team responsible for taking the company public. She then led the Strategic Innovations Group at Pfizer as part of their Corporate Business Development and Strategy Practice where she acquired and launched new businesses leveraging technology. She has over 20 years’ experience leading start-ups, spin-outs and spin-ins including Scient, Revolution Health, and RediClinic which have either gone public or been (re) acquired by Fortune 500 companies.
Aimee is a proud ovarian cancer survivor and serves as a board member at several genetics-based companies and foundations, including Clearity Foundation where she also leads technology and patient advocacy for the organization. Aimee obtained her MBA from Stanford Graduate School of Business, where she completed a Fellowship with Stanford’s Healthcare Economic Team and Governor Pete Wilson to leverage technology to improve health outcomes and reduce costs in the state of California.